Chlorambucil-still not bad: A reappraisal

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue SUPPL.1, 2011, Pages S2-

  Catovsky, Daniel ^a   Else, Monica ^a   Richards, Sue ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

Author keywords

Alkylating agents; Anti CD20 monoclonal antibodies; Chlorambucil; Chronic lymphocytic leukemia; CLL trials

Indexed keywords

BENDAMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; METHYLPREDNISOLONE; MITOXANTRONE; MONOCLONAL ANTIBODY; PREDNISONE; RITUXIMAB; VINCRISTINE;

BONE MARROW TOXICITY; CANCER GROWTH; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; DATA ANALYSIS; DOSE RESPONSE; DRUG MEGADOSE; DRUG RECALL; FEVER; HUMAN; INFECTION; LOW DRUG DOSE; MEDICAL RECORD; NEUTROPENIA; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTOPENIA; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

EID: 83355162841     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.02.006     Document Type: Conference Paper

References (9)

1. Galton DAG, Israels LG, Nabarro JDN, et al. Clinical trials of p-(di-2-chloroethylamine) phenyl butyric acid (CB1348) in malignant lymphoma. Br Med J 1955; ii:1172-86.
2. Catovsky D, Richards S, Fooks J, et al. CLL trials in the United Kingdom: the Medical Research Council Trials 1, 2 and 3. Leuk Lymphoma, 1991; 5 (Suppl 1):105-11.
3. Catovsky D, Richards S, Matutes E, et al. UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group; NCRI Chronic Lym-phocytic Leukaemia Working Group. Assessment of fludarabine plus cyclophospha-mide for patients with chronic lymphocytic leukaemia (the LRF CLL4 trial): a randomised controlled trial. Lancet 2007; 370:230-9.
4. Rai KR, Peterson BL, Appelbaum FR, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343:1750-7.
5. Eichhorst BF, Busch R, Stilgenbauer S, et al; German CLL Study Group (GCLLSG). First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood 2009; 114:3382-91.
6. Hillmen P, Skotnicki AB, Robak T, et al. Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia. J Clin Oncol 2007; 25:5616-23.
7. Knauf WU, Lissichkov T, Aldaoud A, et al. Phase III randomized study of benda-mustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. J Clin Oncol 2009; 27:4378-84.
8. Leporrier M, Chevret S, Cazin B, et al. French Cooperative Group on Chronic Lympho-cytic Leukemia. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood 2001; 98: 2319-25.
9. Jaksic B, Brugiatelli M, Krc I, et al. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna. Cancer 1997; 79:2107-14.